Twenty-four adult participants with type 1 diabetes were randomized to use either the Simplera Sync™ or Instinct sensor for a six-week period, then crossed over to the alternate sensor for an ...
Zacks Investment Research on MSN
MMED's latest study supports the strength of 780G SmartGuard algorithm
MiniMed Group, Inc. MMED recently announced results from a new randomized crossover study showing that glycemic outcomes ...
The MarketWatch News Department was not involved in the creation of this content. NORTHRIDGE, Calif., March 10, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a global leader in full stack ...
GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that ...
GALWAY, Ireland, Dec. 2, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated ...
Please provide your email address to receive an email when new articles are posted on . Patients using the MiniMed 780G had a small increase in time in range after switching to the Instinct CGM sensor ...
NORTHRIDGE, Calif., March 10, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a global leader in full stack insulin delivery, today announced CE (Conformité Européenne) Mark for use of the ...
Medtronic plc MDT has begun the broad U.S. commercial rollout of the MiniMed 780G system integrated with Abbott’s ABT Instinct sensor, designed exclusively for MiniMed systems. Earlier this year, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results